Enhabit Inc. (EHAB)vsMerck & Company Inc (MRK)
EHAB
Enhabit Inc.
$13.78
-0.07%
HEALTHCARE · Cap: $706.40M
MRK
Merck & Company Inc
$112.37
+0.98%
HEALTHCARE · Cap: $277.36B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 6105% more annual revenue ($65.77B vs $1.06B). MRK leads profitability with a 13.6% profit margin vs -0.4%. MRK earns a higher WallStSmart Score of 50/100 (D+).
EHAB
Hold48
out of 100
Grade: D+
MRK
Hold50
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+77.5%
Fair Value
$50.06
Current Price
$13.78
$36.28 discount
Margin of Safety
-13.8%
Fair Value
$97.84
Current Price
$112.37
$14.53 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 8667.0% YoY
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Areas to Watch
4.7% revenue growth
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -0.5% — below average capital efficiency
Premium valuation, high expectations priced in
4.9% revenue growth
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : EHAB
The strongest argument for EHAB centers on Price/Book, EPS Growth.
Bull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bear Case : EHAB
The primary concerns for EHAB are Revenue Growth, Altman Z-Score, Market Cap.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
EHAB profiles as a turnaround stock while MRK is a value play — different risk/reward profiles.
EHAB carries more volatility with a beta of 0.96 — expect wider price swings.
MRK is growing revenue faster at 4.9% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (50/100 vs 48/100). EHAB offers better value entry with a 77.5% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Enhabit Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Enhabit, Inc. provides home health and hospice services in the United States.
Visit Website →Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?